Top Markets
Coin of the day
PacificHealth Laboratories, Inc. PacificHealth Laboratories, Inc.

PacificHealth Laboratories, Inc.

PHLI
Kedudukan dalam Saham #39560
PacificHealth Laboratories, Inc. (PHLI) specializes in developing and marketing... PacificHealth Laboratories, Inc. (PHLI) specializes in developing and marketing nutritional products designed to boost overall health and enhance athletic performance for consumers both within the United States and internationally. The company's offerings predominantly target key aspects of athletic performance, such as optimal sports performance, proper hydration, sustained energy (fueling), and efficient muscle recovery. PHLI's product line includes notable items like ENDUROX R4, a drink formulated for muscle recovery; ACCELERADE, a protein-powered sports beverage; energy gels such as ACCEL GEL and 2ND SURGE; the exercise supplement ENDUROX EXCEL; and Body Glove Surge. Additionally, they provide ACCELERADE HYDRO, a specific formulation for less intense workouts, which supports hydration, energy, and recovery before, during, and after physical activity. Reaching consumers through diverse distribution channels, PHLI's products are available in sports specialty and natural product retailers and chains, as well as directly through their official website. PacificHealth Laboratories, Inc. was founded in 1995 and is headquartered in Matawan, New Jersey.
Harga Saham
$0.0001
Disegerakkan terakhir: 2025-02-11
Modal Pasaran
$438.31K
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan PacificHealth Laboratories, Inc. (PHLI)
EPS untuk PacificHealth Laboratories, Inc. (PHLI)
EPS setakat 2026 TTM: 0
Menurut laporan kewangan terkini dan harga saham PacificHealth Laboratories, Inc., EPS semasa syarikat (TTM) adalah 0. Pada akhir tahun 2026, syarikat mempunyai EPS sebanyak 0 sama dengan EPS tahun 2026 iaitu 0.
Sejarah EPS untuk PacificHealth Laboratories, Inc. dari 2026 hingga 2026
EPS pada akhir setiap tahun
Tahun EPS Ubah
Tidak cukup data untuk tarikh yang disediakan.
EPS untuk syarikat atau pesaing yang serupa